Buchinger W, Tiran B, Langsteger W, Lorenz O, Eber O
Abteilung für Innere Medizin und Nuklearmedizin, Krankenhauses der Barmherzigen Brüder, Graz-Eggenberg.
Acta Med Austriaca. 1993;20(1-2):20-3.
In 7 hyperthyroid patients on the one hand thyroxine-binding globulin (TBG) was determined by commercially available radioimmunoassay and on the other hand TBG-isovariants were established by means of isoelectric focusing. For assessment blood samples were taken upon admittance to our hospital and 2 and 4 weeks thereafter, respectively, during antithyroid drug treatment. A comparative series of 10 euthyroid subjects were equally evaluated. Both groups showed no significant differences of TBG values at onset and in the course of antithyroid treatment. However, TBG isovariants showed significant decreases in anionic bands (pH 4.25 to 4.45) whereas a significant increase in cathodic bands (pH 4.55 to 4.65) at onset of treatment compared to the euthyroid control group could be observed. During the course of antithyroid treatment the values of TBG-isobands reversed reaching the pattern of normal group. In contrast to the recent research by Hashizume et al. we observed no reduction in TBG level in hyperthyroid patients although a significant shift in the TBG isovariants could be established. Due to the antithyroid treatment prescribed, the TBG isovariants finally reached the normal pattern of euthyroid controls.
对7例甲状腺功能亢进患者,一方面通过市售放射免疫分析法测定甲状腺素结合球蛋白(TBG),另一方面通过等电聚焦法确定TBG异构体。为进行评估,在患者入院时以及之后接受抗甲状腺药物治疗的第2周和第4周分别采集血样。对10例甲状腺功能正常的受试者组成的对照系列进行了同样的评估。两组在抗甲状腺治疗开始时和治疗过程中的TBG值均无显著差异。然而,与甲状腺功能正常的对照组相比,治疗开始时TBG异构体的阴离子带(pH 4.25至4.45)显著减少,而阴极带(pH 4.55至4.65)显著增加。在抗甲状腺治疗过程中,TBG等带的值发生逆转,达到正常组的模式。与桥爪等人最近的研究相反,我们观察到甲状腺功能亢进患者的TBG水平没有降低,尽管可以确定TBG异构体有显著变化。由于所开的抗甲状腺治疗药物,TBG异构体最终达到了甲状腺功能正常对照组的正常模式。